Omega Therapeutics

Omega Therapeutics™ is a preclinical-stage genomic medicine company that transforms medicine and patient care through precise genomic control. The company’s platform focuses on selectively guiding the human genome to treat and cure diseases by precisely regulating genomic expression without altering the nucleic acid sequence. Omega Therapeutics is developing precision therapies for a range of disease indications, including rare genetic disorders, immunology, inflammation, metabolic diseases, and oncology.